Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LRP10 Activators

LRP10 activators encompass a variety of chemical compounds that influence cellular signaling pathways to enhance the protein's functional activity. For instance, certain activators target the cAMP signaling pathway by facilitating the production of cAMP or preventing its degradation, thereby indirectly promoting the activation of LRP10 through cAMP-dependent protein kinase (PKA) activation. This can be achieved either by direct activation of adenylyl cyclase or through the inhibition of phosphodiesterases, which are responsible for breaking down cAMP. This elevation in cAMP levels activates PKA, which may lead to subsequent phosphorylation events that enhance LRP10 signaling. Additionally, some activators work by permanently activating the Gs alpha subunit of G-protein coupled receptors, leading to a sustained increase in cAMP levels that could amplify LRP10 activity.

Other mechanisms of action include the manipulation of intracellular calcium levels, which play a significant role in cell signaling. Certain activators operate as calcium ionophores, raising the intracellular concentration of calcium ions, which may trigger calcium-dependent signaling cascades that indirectly influence LRP10 activity. For example, alterations in calcium homeostasis can activate kinases or other calcium-responsive elements within the cell, creating a conducive environment for LRP10 activation. Furthermore, some activators directly modulate kinase activity, such as PKC, or interfere with tyrosine kinase signaling, which can indirectly lead to the upregulation of LRP10.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

A non-selective inhibitor of phosphodiesterases, it elevates cAMP and cGMP levels in cells, possibly enhancing LRP10 function via PKA activation.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Inhibits phosphodiesterase 4 (PDE4), increasing intracellular cAMP levels which can lead to activation of PKA potentially increasing LRP10 activity.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

A cAMP analog that activates PKA. It can bypass adenylyl cyclase activation, possibly leading to enhanced LRP10 activation through PKA signaling.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$94.00
$186.00
71
(2)

A PKA inhibitor that could lead to compensatory upregulation of cAMP levels, indirectly promoting LRP10 activation through increased cAMP signaling.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C (PKC) which might play a role in LRP10 mediated signaling pathways, indirectly leading to increased LRP10 activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

A calcium ionophore that raises intracellular calcium levels, potentially enhancing LRP10 signaling through calcium-dependent pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A calcium ionophore that increases intracellular calcium concentration, which could indirectly activate LRP10 through calcium-mediated signaling.

Nitrendipine

39562-70-4sc-201466
sc-201466A
sc-201466B
50 mg
100 mg
500 mg
$109.00
$160.00
$458.00
6
(1)

A calcium channel blocker that alters calcium homeostasis, potentially leading to activation of LRP10 via altered calcium signaling pathways.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

A beta-adrenergic agonist that increases cAMP levels through Gs protein-coupled receptors, potentially enhancing LRP10 activation through PKA.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

A tyrosine kinase inhibitor that may alter signaling pathways, potentially leading to the upregulation of LRP10 functional activity.